SCHEMBL3036402

SCHEMBL3036402

Cc1nc(Cl)c(C(=O)NCc2cc(C#N)c(Cl)c(Oc3cc(Cl)cc(C#N)c3)c2F)[nH]1

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.42
KCNH2 Q12809 2/20 0.36
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 1/20 0.35
EPAS1 Q99814 3/20 0.33
VEGFA P15692 2/20 0.33
ARNT P27540 1/20 0.33
SLC22A12 Q96S37 1/20 0.32
CYP2D6 P10635 1/20 0.30
PKM P14618 1/20 0.30
MAPK1 P28482 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3022142 0.95 CYP3A4 (0.39) CYP3A4KCNH2CYP2C9CYP2C19EPAS1
SCHEMBL3033597 0.91 CYP3A4 (0.41) CYP3A4KCNH2CYP2C9CYP2C19EPAS1
SCHEMBL3027159 0.88 CYP3A4 (0.54) CYP3A4KCNH2CYP2C9CYP2C19EPAS1
SCHEMBL3017381 0.88 CYP3A4 (0.49) CYP3A4KCNH2CYP2C9CYP2C19PKM
SCHEMBL3027526 0.88 CYP3A4 (0.46) CYP3A4KCNH2CYP2C9CYP2C19EPAS1
Trifluoroacetic Acid SCHEMBL3028190 0.87 CYP3A4 (0.39) CYP3A4KCNH2CYP2C9CYP2C19EPAS1
SCHEMBL3023960 0.87 CYP3A4 (0.43) CYP3A4KCNH2CYP2C9CYP2C19EPAS1
SCHEMBL3023375 0.86 CYP3A4 (0.45) CYP3A4KCNH2CYP2C9CYP2C19EPAS1
SCHEMBL3036184 0.85 CYP3A4 (0.44) CYP3A4KCNH2CYP2C9CYP2C19PKM
SCHEMBL3032846 0.85 CYP3A4 (0.44) CYP3A4KCNH2CYP2C9CYP2C19EPAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 US claimed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 US claimed
EP-2166856-A1 CHEMICAL COMPOUNDS GlaxoSmithKline LLC (US) 2010-03-31 EP claimed
WO-2008154271-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-18 WO claimed
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 US disclosed
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 US disclosed
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 US disclosed
EP-2166856-A1 CHEMICAL COMPOUNDS GlaxoSmithKline LLC (US) 2010-03-31 EP disclosed
WO-2008154271-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216746-A1 CHEMICAL COMPOUNDS SAMHD1, POLRMT, NUDT1 CYP3A4 169/4885KCNH2 4114/4885CYP2C9 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.